Beta-amyloid-directed multitarget compounds for the treatment of alzheimer's disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9238626
APP PUB NO 20150099776A1
SERIAL NO

14400314

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The compounds of formula (I), or its pharmaceutically acceptable salts, or any stereoisomer or mixture thereof, wherein: R1 is a (C1-C2) alkyl radical; R2 and R3 are radicals independently selected from the group consisting of F, CI and methyl R4 is H or OH; A is a birradical selected from the group consisting of —(CH2)n— and —(CH2)-phenyl-(CH2)—; t is an integer from 0 to 1; and n is an integer from 8 to 15, are useful for the treatment of Alzheimer's disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITAT DE BARCELONA08028 BARCELONA
PONTIFICIA UNIVERSIDAD CATOLICA DE CHILEAV LIBERTADOR BERNARDO O’HIGGINS 340 SANTIAGO 8331150

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Inestrosa, Cantín Nibaldo Manuel Santiago de Chile, CL 1 0
Muñoz-Torrero, López-Ibarra Diego Viladecans, ES 3 0
Sola, Lao Irene Terrassa, ES 1 0
Vázquez, Cruz Santiago Cornellà de Llobregat, ES 7 0
Viayna, Gaza Elisabet Alella, ES 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 19, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00